Work

Recipient CCL5 −403G>A (rs2107538) Polymorphism and Acute Graft-Versus-Host Disease in Pediatric Hematopoietic Cell Transplantation

Year: 2026
Type: article
Study design: Observational Study
Abstract: Acute graft-versus-host disease (aGvHD) is a clinically important immune complication after allogeneic hematopoietic cell transplantation (HCT). Chemokines play a pivotal role in regulating leukocyte migration and recruitment to inflamed tissues, thereby contributing to the immunopathogenesis of aGvHD. In particular, CCL5 mediates the recruitment of CCR1-, CCR3-, and CCR5-expressing immune cells, suggesting that regulatory polymorphisms in the CCL5 gene may influence inflammatory cell trafficking and recipient susceptibility to aGvHD. In this retrospective single-center candidate-gene study, we evaluated recipient CCL5 −403G>A (rs2107538), CCR9 G926A (rs12721497), and CXCL12 3′A>G (rs1801157) polymorphisms in 62 pediatric HCT recipients. CCR9 and CXCL12 were analyzed as biologically selected comparator loci within chemokine receptor and hematopoietic trafficking pathways, whereas the primary association signal was observed for CCL5. Genotypes were determined by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) and analyzed according to aGvHD status. Acute GvHD occurred in 25 patients (40.3%). Patients without aGvHD were classified as grade 0; grade 0–I and grade II–IV groups comprised 40 (64.5%) and 22 (35.5%) patients, respectively. The CCL5 rs2107538 variant showed a significant association with aGvHD, with enrichment of the GA genotype and A allele among affected patients, whereas the GG genotype was more frequent in patients without aGvHD. No significant associations were detected for recipient CCR9 rs12721497 or CXCL12 rs1801157. This pattern suggests that a promoter-region CCL5 variant, rather than the evaluated CCR9 or CXCL12 loci, may be the most relevant chemokine-related susceptibility signal in this pediatric cohort. The finding is exploratory and does not establish causality or clinical eligibility criteria for HCT, but it provides a focused rationale for donor–recipient paired studies and functional assessment of CCL5 transcriptional regulation in aGvHD.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236712317
FWCI:
Cites: 27
Cited by:
Related to: 10